InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by DeRose Kathleen, 董事. Officer active across 1 company, notably Enfusion, Inc.. Cumulatively, 6 disclosures have been logged. History available since 31 October 2021. The latest transaction was disclosed on 13 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to DeRose Kathleen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
60,716 股Class A Common StockSEC:0001104659-25-036895:0
13,470 股0Class A Common StockSEC:0001104659-24-072471:0
15,233 股0Class A Common StockSEC:0001104659-23-075806:0
2,791 股0Class A Common StockSEC:0001104659-22-130961:0
12,678 股0Class A Common StockSEC:0001104659-22-072526:0
11,029 股0Class A Common StockSEC:0001104659-21-133213:0
6 条申报中的 6 条
About DeRose Kathleen
Kathleen DeRose is a Board Member at Enfusion, Inc. In this role, she participates in overseeing the company's activities and making strategic decisions. Her experience in the fintech sector allows her to make significant contributions to the board.
